The Weight Is Over—Novo Nordisk Officially Launches Wegovy at ₹17,345/month in India

Unknown Apr 02, 2026 1,300 Views

Novo Nordisk India formally introduced its much-awaited weight-reduction injectable drug, Wegovy (semaglutide), in India, marking a major milestone in the country's obesity treatment market. Managing Director Vikrant Shrotriya unveiled the launch on June 24, 2025, with distribution alread...